Dova Pharmaceuticals, Inc. (Nasdaq: DOVA) to Ring The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
136
Dova Pharmaceuticals, Inc. (Nasdaq: DOVA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO

ADVISORY, June 29, 2017 (GLOBE NEWSWIRE) --

What:  Dova Pharmaceuticals, Inc. (Nasdaq: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet need, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).

In honor of the occasion, Alex Sapir, President & CEO, will ring the Opening Bell. 

Where: Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio

When: Thursday, June 29, 2017 – 9:15 a.m. to 9:30 a.m. ET      

Dova Pharmaceuticals Media Contact: Douglas Blankenship (919) 806-4487 dblankenship@dova.com

Nasdaq MarketSite: Emily Pan (646) 441-5120 emily.pan@nasdaq.com

Feed Information: Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media: For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ .

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/

Webcast: A live stream of the Nasdaq Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.            

About Dova Pharmaceuticals, Inc. Dova is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia. The company's lead drug candidate, avatrombopag, recently completed two pivotal Phase 3 clinical trials for the treatment of thrombocytopenia in patients with chronic liver disease undergoing planned medical procedures.

About Nasdaq Nasdaq (Nasdaq: NDAQ ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com

-NDAQA-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CURE Intl and Thoughtworks Step Into Digital Era

Updated Category News Views 42

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Continue Reading
NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 122

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 104

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading
Global Vineyards List: New Entrants & Rankings Unveiled

Updated Category News Views 232

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Continue Reading
Upsher-Smith Rolls Out New Eye Solutions, Impacts Market

Updated Category News Views 59

Upsher-Smith's Bold Move in Ophthalmics Right out of Maple Grove, Minnesota, Upsher-Smith Laboratories is shaking up the eye care scene with the launch of two strengths of Brimonidine Tartrate Ophthalmic Solution. We're talking 0.1% and 0.15%, folks. This ain't just a dribble in the ocean—these products are sailing into a $115 million market arena, according to IQVIA....

Continue Reading
D-Wave Faces Lawsuit: Investors Eye December Deadline

Updated Category News Views 39

The dance of legal papers and the roar of share prices, buddy—sometimes they tango together in a courtroom like this spectacle with D-Wave Quantum Inc. (NASDAQ: QBTS). This isn’t your typical boardroom skirmish; there’s a full-blown class action lawsuit brewing, and investors have until December 15, 2026, to throw their hats in for the lead plaintiff gig. What's...

Continue Reading
Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 82

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Empyrean Eases Public Sector Benefits with OMNIA Deal

Updated Category News Views 126

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...

Continue Reading
24X Partners with Standard Chartered for Crypto Leap

Updated Category News Views 21

24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...

Continue Reading
Chicago Marathon Spurs $1M for Suicide Prevention

Updated Category News Views 49

Marathon Fundraising Hits New Heights Surpassing a million bucks in one marathon run—a result you don't see every day. Yet, that's what happened when the AFSP's Race for Hope team took to the Chicago streets. October 11, 2026, tagged them as fundraising champs, setting an Illinois record for suicide prevention efforts. A Journey of Passion and Purpose What started 16...

Continue Reading

Top 5 Most Recently Viewed Articles

Fly-E Group, Inc. Reports Significant Financial Updates

Updated Category News Views 263

Fly-E Group Financial Highlights Fly-E Group, Inc. (NASDAQ: FLYE), a leader in the electric vehicle sector focusing on smart electric motorcycles, bikes, and scooters, has released its financial results for the first quarter of fiscal year 2026. Financial Summary for the First Quarter In this quarter, the company's net revenues reached $5.3 million, reflecting a decrease...

Continue Reading
Innovative Carbon Capture Project Secured £1.1 Million Funding

Updated Category News Views 198

Seabound Welcomes Significant Funding for Carbon Capture Initiatives Seabound, a prominent player in the marine carbon capture sector, has recently been awarded a £1.1 million grant as part of the UK Government's Clean Maritime Demonstration Competition. In partnership with STAX Engineering and Associated British Ports (ABP), this grant aims to support pioneering efforts...

Continue Reading
Navigating Election Stress: Mindfulness Techniques for All

Updated Category News Views 59

Mindfulness for Election Anxiety In today’s fast-paced world, especially during election seasons, many people experience heightened stress and anxiety. The Frederick P. Lenz Foundation for American Buddhism recognizes this struggle and invites everyone to participate in a free, engaging webinar titled "Overcoming Election Anxiety with Mindfulness." This insightful event...

Continue Reading
Hoffmann Green Partners with Piscines Magiline for Sustainability

Updated Category News Views 93

Hoffmann Green Cement Technologies is making waves in the sustainability pool with its new partnership with Groupe Piscines Magiline, aiming to turn traditional construction on its head. This strategic collaboration, stretching until 2026, targets the swimming pool construction sector by promoting clinker-free cement solutions. In short? They're positioning themselves as...

Continue Reading
Exploring Diverse Job Market Views: A 2025 Overview

Updated Category News Views 327

Job Seekers' Perspectives on 2025 Job Market As the new year unfolds, the job market presents a tapestry of opinions among job seekers. A survey revealed that approximately one-third of individuals looking for jobs believe there are fewer opportunities in their desired fields compared to the previous year. In contrast, some remain hopeful and feel that the landscape is...

Continue Reading